Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Rises By 169.9%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 27,721 shares, an increase of 169.9% from the June 30th total of 10,271 shares. Based on an average trading volume of 10 shares, the days-to-cover ratio is currently 2,772.1 days.

Laboratorios Farmaceuticos Rovi Price Performance

Laboratorios Farmaceuticos Rovi stock remained flat at C$64.77 during midday trading on Wednesday. Laboratorios Farmaceuticos Rovi has a one year low of C$65.86 and a one year high of C$65.86. The stock has a 50 day moving average price of C$65.65 and a 200-day moving average price of C$65.79.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmacéuticos ROVI SA is a Spanish specialty pharmaceutical company focused on the development, manufacturing and commercialization of injectable therapies. The company has built expertise in low-molecular-weight heparins and long-acting injectable antipsychotics, alongside drug-delivery technologies such as prefilled syringes and autoinjector systems. ROVI’s product portfolio spans both originator and biosimilar medicines, targeting therapeutic areas including psychiatry, oncology and cardiology.

ROVI’s core franchise includes established anticoagulant products based on tinzaparin sodium, as well as innovative depot formulations of risperidone developed using its proprietary in situ microparticle (ISM) technology.